Related Experiment Video
Updated: Apr 26, 2026

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
[Cardiovascular diseases and mannose-binding lectin]
Insights
Mannose-binding lectin (MBL), an innate immunity factor, plays a complex role in acute coronary syndromes (ACS). Its impact on cardiovascular disease pathogenesis, including inflammation and thrombosis, requires further investigation for improved patient outcomes.
Area of Science:
- Innate immunity and cardiovascular disease research.
- Molecular mechanisms of complement activation.
- Pathogenesis of atherosclerosis and acute coronary syndromes.
Context:
- The role of innate immunity factors in acute coronary syndromes (ACS) is underexplored.
- Mannose-binding lectin (MBL) is a key humoral innate immune factor activating complement pathways.
- Existing literature presents a complex and often contradictory role for MBL in cardiovascular diseases.
Purpose:
- To review and synthesize current literature on the impact of Mannose-binding lectin (MBL) on atherosclerosis, ischemic heart disease, and ACS.
- To explore the multifaceted role of MBL in the pathogenesis of cardiovascular events.
- To discuss the genetic basis of MBL deficiency and its implications.
Summary:
- Mannose-binding lectin (MBL) influences key pathogenic links in ACS, including inflammation, thrombosis, and apoptosis.
- MBL's involvement spans atherogenesis, from plaque formation and destabilization to thrombotic events.
- The review covers MBL's function in innate immunity, MBL2 gene variations, MBL deficiency, and its role in various diseases.
Impact:
- Highlights the potential of MBL as a therapeutic target or prognostic marker in ACS.
- Provides a comprehensive overview for researchers investigating innate immunity in cardiovascular pathology.
- Informs clinical understanding of MBL's dual role, potentially improving patient risk stratification and management.
Abstract:
The role of innate immunity factors in the pathogens of ACS is not well studied, although there is evidence in the literature about their impact on the course of cardiovascular diseases. Mannose-binding lectin (MBL)--one of the key factors of the humoral innate immune system that activates one of complement activation pathways. The literature suggests an ambiguous, complex role of MBL, which can in different clinical situations either improve the prognosis of patients, or be a risk factor for complications. MBL could potentially be relevant to all main links in the pathogenesis of coronary artery disease and myocardial infarction: inflammation, thrombosis, apoptosis, and so on. At different stages of atherogenesis, including the formation and destabilization of the atherosclerotic plaque, thrombosis, MBL may have a significant impact. The review analyzes currently available literature on the impact of MBL on atherosclerosis, ischemic heart disease and acute coronary syndrome. Moreover, in the review there is data on the role of MBL in physiological reactions in innate immunity, gene structure of MBL2 and possible mutations leading to deficiency of MBL in blood, and the role of MBL in the pathogenesis of various diseases.
Related Concept Videos
Coronary Artery Disease I: Introduction
Selectins
Proteoglycans
Diabetes Mellitus: Type 2 and Gestational
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy

